2014

Patient and Healthcare Worker Safety Major Areas of Focus at B.Braun B.Braun Portfolio Showcased at APIC - Leading Professional Association for Infection Preventionists

BETHLEHEM, Pa., June 7, 2013 /PRNewswire/ -- Catheter-related bloodstream infections (CRBSIs), needlestick (sharps) injuries and exposure to potentially deadly blood borne pathogens continue to be major areas of concern for healthcare workers throughout the U.S.

"We are committed to addressing these issues by providing a robust portfolio of safety-engineered IV therapy devices that offer patient protection against infection and optimum safety in the workplace," said Tom Sutton, Vice President of Vascular Access Systems at B.Braun.

B. Braun Medical Inc. (B.Braun) will exhibit (booth #1316) its safety-engineered IV therapy devices at the 40th Annual Association for Professionals in Infection Control and Epidemiology (APIC) Conference, in Fort Lauderdale, Florida, June 8-10. 

B.Braun 's portfolio includes safety-engineered IV therapy devices such as:

  • Introcan Safety® IV Catheter, which is designed with innovative passive-safety features to help eliminate accidental needlestick injury - effortlessly. From insertion to catheter deployment to needle removal, clinicians are protected by a truly passive safety device that is activated automatically - no extra steps required and cannot be bypassed.
  • Introcan Safety® 3 Closed IV Catheter, B.Braun's latest innovation, which takes the same preferred passive safety-engineered needlestick protection found in Introcan Safety and adds additional protection from blood exposure. For safety and convenience, the Introcan Safety 3's unique multi-access blood control septum minimizes blood exposure during needle removal and each time the catheter hub is accessed.
  • The ULTRAPORT™ series of stopcocks, were designed in response to growing concerns about stopcock contamination. They feature disinfectable luer activated connectors that are more effective than conventional caps in preventing the passage of microorganisms in the catheter lumen. ULTRAPORT and ULTRAPORT zer0 luer-activated high-flow stopcocks, offer closed system protection against CRBSI and are designed to prevent contamination and leaks without caps. Research shows that infection control measures in the anesthesia work area may help reduce infections.1
  • Caresite® Luer Access Device, the latest in B.Braun's needleless connector portfolio that offers a safe way to access IV lines without the use of a needle, which reduces the risk of accidental needlestick injuries. Input from clinicians provided the basis for the CARESITE design. The result is a device designed to help improve patient outcomes and clinician efficiency. CARESITE needleless connector with innovative positive displacement feature is designed to help reduce catheter occlusions while preventing healthcare workers from accidental needlestick injuries.

Attendees will be able to sign-up at B.Braun's booth (#1316) to receive reprints of studies that will inform them about the infections risks to healthcare workers from needlestick injuries and blood exposure with peripheral IV catheters and about the relative safety profiles of active vs. passive safety-engineered IV catheter designs. In addition, they will be able to order reprints that will inform them about the transmission of pathogenic bacterial organisms and the prevention of intravenous bacterial injection from healthcare provider hands. 

To learn more about B.Braun visit www.bbraunusa.com

About B.Braun

B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its "Sharing Expertise®" philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.

The B.Braun Group of Companies in the U.S. includes B.Braun, Aesculap® and CAPS®. B.Braun's U.S. headquarters is located in Bethlehem, Pennsylvania. The B.Braun Group of Companies employs more than 46,000 employees in more than 50 countries throughout the world. To learn more about B.Braun visit www.BBraunUSA.com.

1Loftus R, Koff MD, Burchman CC., et al. Transmission of pathogenic bacterial organisms in the anesthesia work area. Anesthesiology. 2008. 109:3

SOURCE B. Braun Medical Inc.



RELATED LINKS
http://www.bbraunusa.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.